APA

Voora D., Koboldt D. C., King C. R., Lenzini P. A., Eby C. S., Porche-Sorbet R., Deych E., Crankshaw M., Milligan P. E., McLeod H. L., Patel S. R., Cavallari L. H., Ridker P. M., Grice G. R., Miller R. D. & Gage B. F. (20100416). A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. : Clinical pharmacology and therapeutics.

Chicago

Voora D, Koboldt D C, King C R, Lenzini P A, Eby C S, Porche-Sorbet R, Deych E, Crankshaw M, Milligan P E, McLeod H L, Patel S R, Cavallari L H, Ridker P M, Grice G R, Miller R D and Gage B F. 20100416. A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. : Clinical pharmacology and therapeutics.

Harvard

Voora D., Koboldt D. C., King C. R., Lenzini P. A., Eby C. S., Porche-Sorbet R., Deych E., Crankshaw M., Milligan P. E., McLeod H. L., Patel S. R., Cavallari L. H., Ridker P. M., Grice G. R., Miller R. D. and Gage B. F. (20100416). A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. : Clinical pharmacology and therapeutics.

MLA

Voora D, Koboldt D C, King C R, Lenzini P A, Eby C S, Porche-Sorbet R, Deych E, Crankshaw M, Milligan P E, McLeod H L, Patel S R, Cavallari L H, Ridker P M, Grice G R, Miller R D and Gage B F. A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans. : Clinical pharmacology and therapeutics. 20100416.